Discussion of the “White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs”

2007/11/08 by Andrew P. Grieve · 1 voice
Decision Sciences · Economics, Econometrics and Finance · Mathematics · #Health Systems, Economic Evaluations, Quality of Life #Optimal Experimental Design Methods #Statistical Methods in Clinical Trials

paper · doi:10.1080/10543400701643855

openalex publication_date 2007/11/08 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

I welcome the timely publication of the White Paper prepared by the PhRMA Working group on Adaptive Dose-ranging Designs. It appears at an important juncture in the young history of the application...

Discussions

• Agreed. I introduced the term "Eierlegendewollmilchsau” (Egg-laying-woolly-milk giving pig) into adaptive design literature (doi.org/10.1080/1054...) to describe a clinical trial that can answer many [bsky, 2 points, 0 comments]

Related

• Hormesis: The Dose-Response Revolution
• LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
• Claiming trend in toxicological and pharmacological dose-response studies: an overview on statistical methods and related R-Software
• DROID: Dose-ranging Approach to Optimizing Dose in Oncology Drug Development
• Adaptive Phase 2/3 Design with Dose Optimization